Search

AstraZeneca PLC

Closed

SectorHealthcare

183.89 -0.68

Overview

Share price change

24h

Current

Min

183.07

Max

186.48

Key metrics

By Trading Economics

Income

599M

3.1B

Sales

609M

16B

P/E

Sector Avg

26.788

68.089

EPS

2.79

Dividend yield

1.73

Profit margin

19.23

Employees

96,100

EBITDA

741M

5.9B

Recommendations

By TipRanks

Recommendations

Strong Buy

12 Months Forecast

+16.78% upside

Dividends

By Acuity

Dividend yield

Sector Avg

1.73%

1.98%

Next Earnings

9 Feb 2027

Market Stats

By TradingEconomics

Market Cap

4.4B

294B

Previous open

184.57

Previous close

183.89

AstraZeneca PLC Chart

Past performance is not a reliable indicator of future results.

Related News

11 Nov 2026, 23:51 UTC

News

A class action lawsuit has been filed against lululemon athletica Inc. for allegedly concealing declining demand and overstating its turnaround plan effectiveness.

11 Nov 2026, 23:51 UTC

News

Blackstone Life Sciences enters a co-funding agreement with Pfizer, committing up to $1.5 billion for the development of obesity treatment berobenatide through 2028.

11 Nov 2026, 23:36 UTC

News
Event

Coherus Oncology enters a clinical supply agreement with Oncolytics Biotech to evaluate pelareorep with LOQTORZI for squamous cell anal carcinoma, starting Q1 2027.

11 Nov 2026, 23:31 UTC

News

Block, Inc. is trading modestly lower in after-market hours, reflecting a significant decline in the broader market amid ongoing geopolitical tensions and economic anxieties.

11 Nov 2026, 23:26 UTC

News

UBS maintained its Buy rating on TransDigm Group and lowered its price target to $1.48k, contributing to after-market gains.

11 Nov 2026, 23:21 UTC

News
Event

Guardant Health intends to offer $500 million in convertible senior notes due 2032, with an option for an additional $50 million.

11 Nov 2026, 23:16 UTC

News

Kinsale Capital Group Inc. declared a quarterly dividend of $0.25 per share, payable on December 14, 2026, to stockholders of record on November 30, 2026.

11 Nov 2026, 23:06 UTC

News
Correlated Moves

The USD/SGD is little changed, positioned near the upper end of its one-month range, amid expectations of tighter Federal Reserve monetary policy.

11 Nov 2026, 23:06 UTC

News
Macro News

Michael Saylor's strategy has been removed from MSCI indexes, potentially leading to sell-offs from passive funds amid ongoing U.S. interest in Bitcoin acquisition.

11 Nov 2026, 23:03 UTC

News
Social Media

Alphabet Inc. launched AlphaGenome 2, an AI model that identifies DNA changes linked to diseases, reportedly detecting nearly twice as many changes as previous versions.

11 Nov 2026, 23:03 UTC

News
Social Media

Alphabet Inc. launched AlphaGenome 2, an AI model that identifies nearly twice as many DNA changes associated with diseases, enhancing genetic research capabilities.

11 Nov 2026, 23:03 UTC

News
Social Media

EZCORP Inc reported fourth-quarter fiscal 2026 net income of $34.3 million, a 28% increase, and total revenues of $447.1 million, surpassing estimates.

11 Nov 2026, 23:03 UTC

Social Media
News
Correlated Moves

Teekay Tankers Ltd. reported third-quarter GAAP net income of $195.2 million and adjusted EPS of $5.04, exceeding estimates and declaring a $0.25 dividend.

11 Nov 2026, 23:03 UTC

News

MSCI will remove Strategy Inc. from its global equity benchmarks, classifying it as a non-operating business, effective November 30, potentially triggering $2.8 billion in stock sales.

11 Nov 2026, 23:03 UTC

Correlated Moves
News

Visa Inc. is experiencing modest gains in after-market trading, reaching its highest point since Wednesday's close and significantly above its 20-day moving average.

11 Nov 2026, 23:03 UTC

News
Correlated Moves
Social Media

Coinbase Global, Inc. shares are lower in after-market hours amid a broader market decline, despite users highlighting strong month-over-month growth in new businesses.

11 Nov 2026, 23:03 UTC

News
Event

Eli Lilly reports positive results from the TOGETHER-PsA trial, showing Taltz and Zepbound's efficacy in treating psoriatic arthritis with weight-related comorbidities.

11 Nov 2026, 23:03 UTC

News
Correlated Moves
Social Media

Tesla Inc shares are modestly lower in after-market trading, following a decline earlier in the session, alongside a drop in the Invesco QQQ Trust.

11 Nov 2026, 23:03 UTC

Macro News
News
Correlated Moves

The Japanese yen weakened against the U.S. dollar, trading around 159.59, amid a broader dollar rally and expectations for tighter Fed monetary policy.

11 Nov 2026, 23:03 UTC

News
Correlated Moves

Oracle Corporation's shares declined during after-market hours, reflecting a broader market downturn amid ongoing geopolitical tensions and inflation concerns.

11 Nov 2026, 23:03 UTC

Event
News
Social Media

NVIDIA shares declined sharply in after-hours trading amid reports of CEO Jensen Huang facing potential ousting due to allegations of extramarital affairs.

11 Nov 2026, 23:03 UTC

News
Social Media

Tetra Tech, Inc. reported Q4 revenue of $1.34 billion and adjusted EPS of $0.49, exceeding estimates, while backlog increased 13% to $4.67 billion.

11 Nov 2026, 23:02 UTC

News

Invitation Homes Inc. appointed M. Colin Connolly as a board member, effective November 13, 2026, increasing the board's membership to ten.

11 Nov 2026, 23:02 UTC

News
Event

Alvotech SA reported a Q3 loss per share of -$0.23 and sales of $111.6 million, missing estimates, contributing to a decline in after-market trading.

11 Nov 2026, 23:02 UTC

News

CareTrust REIT, Inc. launched a public offering of 17 million shares, with Bank of America and Morgan Stanley as underwriters, leading to a decline in after-hours trading.

11 Nov 2026, 23:02 UTC

News
Correlated Moves

USD/PLN is trading higher as stronger-than-expected inflation data raises expectations for a Federal Reserve interest rate hike next month.

11 Nov 2026, 23:02 UTC

News
Social Media

Advanced Micro Devices, Inc. shares advanced in after-market trading following a record $13.4 billion revenue report and guidance for fourth-quarter revenue around $17 billion.

11 Nov 2026, 23:02 UTC

News
Correlated Moves

Applied Materials Inc is lower in after-market hours, influenced by rising inflation concerns and geopolitical tensions affecting the semiconductor sector.

11 Nov 2026, 23:02 UTC

News
Correlated Moves

The U.S. dollar strengthened today, with USD/CZK modestly higher following stronger-than-expected inflation data and Fed Governor Waller's comments on persistent inflation.

11 Nov 2026, 23:01 UTC

News

OptimizeRx reports Q3 revenue of $21.6 million, down 17% year-over-year, and revises FY 2026 revenue guidance to $87 million-$93 million, below consensus.

Peer Comparison

Price change

AstraZeneca PLC Forecast

Price Target

By TipRanks

16.78% upside

12 Months Forecast

Average 216.61 USD  16.78%

High 274.117 USD

Low 160.459 USD

Based on 17 Wall Street analysts offering 12 month price targets forAstraZeneca PLC - Dist in the last 3 months.

Rating Consensus

By TipRanks

Strong Buy

17 ratings

15

Buy

2

Hold

0

Sell

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About AstraZeneca PLC

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology. Its marketed products also comprise Vaxzevria, Beyfortus, Synagis, FluMist, Soliris, Ultomiris, Strensiq, Koselugo, and Kanuma for covid-19 and rare disease. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Neurimmune AG to develop and commercialize NI006; BenevolentAI for drug discovery for systemic lupus erythematosus; Lunit for developing AI-Powered Digital Pathology Risk Assessment Tools for NSCLC; and Absci Corporation for AI-driven drug discovery against an oncology target. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
help-icon Live chat